iota Biosciences
Focus: iota Biosciences develops implantable bioelectronic devices targeting gastroenterology, neurology, and ophthalmology indications. The company is an early-stage medical device player founded in 2017, based in Alameda, CA.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
2-6 this month
Cooling — net -6 jobs in 30d
2 added, 8 removed. Slower than typical.
Should You Work at iota Biosciences?
AI assessmentiota Biosciences is a speculative early-stage bioelectronics play best suited for risk-tolerant professionals seeking equity upside and core technical influence, not stability.
Why Work Here
- Join a cutting-edge bioelectronics company with 100% H1B approval rate (6/6 in 2023), signaling strong visa sponsorship and international talent recruitment
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Direct Bladder Wall Stimulation
Underactive BladderOpen Jobs (2)
Help build intelligence for iota Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.